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Objective: To evaluate the effect of the kinesiotherapy in the quality of life, sexual function
and  menopause-related symptoms and compare in climacteric women with and without
ﬁbromyalgia (FM).
Methodology: The group was composed of 90 climacteric women divided in 2 groups: FM (47)
and control (43). The patients were analyzed on their quality of life (Utian Quality of Life
[UQoL]), sexual function (Sexual Quotient-Female Version [SQ-F] questionnaire) and inten-
sity  of the climacteric symptoms (Blatt–Kupperman menopausal index [BKMI]). Both groups
performed pelvic ﬂoor kinesiotherapy, composed of 20 sessions, twice a week. Statistical
analysis was performed using Student’s t-test, mixed-design analysis of variance (ANOVA)
and  Cohen’s Kappa.
Results: In the quality of life, an improvement was noticed in both groups for all domains
analyzed. In the comparison between groups it was noticed a difference in the emotional
(p  = 0.01), health (p = 0.03) and sexual (p = 0.001) domains with considerable gains veriﬁed in
the control group. Improvement was also noticed in the sexual function. In the analysis
between groups, FM group showed a lower score compared to the control group (p < 0.001).With  respect to the climacteric symptoms, there was no difference in the analysis between
rvention (p < 0.001).groups after the inteConclusions: The pelvic ﬂoor kinesiotherapy promotes a positive effect in the domains of
quality of life, sexual function and climacteric symptoms in women with and without
 Work conducted at the Postgraduate Program in Health Sciences,  Universidade Federal do Rio Grande do Norte, and at Universidade
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ﬁbromyalgia in the climacteric period; however, ﬁbromyalgia seems to be a limiting factor
to  achieve better results in some of the aspects evaluated.
© 2015 Elsevier Editora Ltda. All rights reserved.
Efeito  da  cinesioterapia  na  qualidade  de  vida,  func¸ão sexual  e  sintomas
climatéricos  em  mulheres  com  ﬁbromialgia
Palavras-chave:
Fibromialgia
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Abordagem sexual
Climatério
r  e  s  u  m  o
Objetivo: Avaliar e comparar o efeito da cinesioterapia na qualidade de vida, func¸ão sexual
e  sintomas climatéricos em mulheres climatéricas com e sem ﬁbromialgia.
Métodos: Participaram 90 mulheres climatéricas, divididas em dois grupos: ﬁbromialgia (47)
e  controle (43). As pacientes foram avaliadas nas variáveis: qualidade de vida (Utian Quality
of  Life [UQOL]), func¸ão sexual (questionário do quociente sexual/versão feminina [QS-F]) e
intensidade dos sintomas climatérios (Índice Menopausal de Blatt–Kupperman [IMBK]). Os
grupos ﬁzeram cinesioterapia para o assoalho pélvico, composto de 20 sessões, duas vezes
por  semana. Análise estatística foi feita por meio dos testes t de Student pareado, análise
de  variância de delineamento misto e Kappa de Cohen.
Resultados: Na qualidade de vida, foi observada melhoria em ambos os grupos para todos
os  domínios avaliados. Na análise intergrupo foi evidenciada diferenc¸a nos domínios emo-
cional (p = 0,01), saúde (0,03) e sexual (p = 0,001) com ganhos mais expressivos para o grupo
controle. Na func¸ão sexual, foi veriﬁcada melhoria nos grupos, após a intervenc¸ão; na análise
intergrupo as ﬁbromiálgicas apresentaram escores inferiores ao grupo controle (p < 0,001).
Em  relac¸ão aos sintomas climatéricos não houve diferenc¸a na análise intergrupo pós-
intervenc¸ão  (p = 0,73). Entretanto, ambos os grupos apresentaram reduc¸ão signiﬁcativa da
sintomatologia após a intervenc¸ão (p < 0,001).
Conclusões: A cinesioterapia do assoalho pélvico exerce efeito benéﬁco sobre os domínios
da qualidade de vida, func¸ão sexual e sintomatologia climatérica em mulheres com e sem
ﬁbromialgia na fase do climatério. Entretanto, a ﬁbromialgia parece ser fator limitante para
melhores resultados em alguns aspectos avaliados.
© 2015 Elsevier Editora Ltda. Todos os direitos reservados.Introduction
Fibromyalgia is one of the most common rheumatic diseases,
whose main characteristic is a diffuse and chronic muscu-
loskeletal pain.1,2 In addition to the painful condition, patients
often complain of fatigue, sleep disturbances, morning stiff-
ness, paresthesias of the extremities, a subjective feeling
of edema, cognitive disorders, urogynecology disorders and
decreased libido. Although the etiology and pathogenesis
of ﬁbromyalgia is not fully understood, it is recognized as a
complex and heterogeneous clinical entity, depending not
only of biological mechanisms but also of inﬂuences of the
psychosocial context.3,4 The diagnosis remains a complex
challenge for clinicians, by covering a variety of aspects,
including the fact that it is based solely on the perception
of symptoms by the patient, absence of an objective test to
conﬁrm or deny the diagnosis and the unpredictable response
to various existing treatments. What is known is that, in
most patients, the pain and symptoms associated determine
3a negative impact on quality of life.
Studies have reported that about 80–0% of cases of
ﬁbromyalgia occur in the female population4,5 and that
women exhibit signiﬁcantly more  symptoms than men.6Considering that the highest prevalence of the disease occurs
between 50 and 65 years of age,7,8 which coincides with the
climacteric period, some signs and symptoms of ﬁbromyal-
gia can often be confused with menopause-related symptoms.
Therefore, it is common that many  patients initially seek
medical care with generalist physicians and gynecologists,
which reinforces the importance of investigating the associa-
tion between menopause and ﬁbromyalgia.9,10
Studies examining this association have suggested that
those hormonal disturbances of the menopause may be
directly involved in the genesis of symptoms associated with
ﬁbromyalgia in middle-aged women.10 However, considering
that there are women with ﬁbromyalgia outside the climac-
teric phase, it is clear that the hormonal deﬁcit is not the only
pathophysiological mechanism involved in the genesis of this
disease.10,11
Despite the frequent association between climacteric syn-
drome and ﬁbromyalgia, the literature is still scarce in terms
of evidence from studies involved in the analysis and compar-
ison of some related aspects, such as is the case of climacteric
signs and symptoms, quality of life and sexual function.
This scientiﬁc gap becomes even more  evident in terms
of the impact of complementary therapeutic approaches
such as kinesiotherapy. Given the above, the present study
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imed to analyze the effect of pelvic ﬂoor kinesiotherapy
n menopause related symptoms, quality of life and sex-
al function in women with ﬁbromyalgia in the climacteric
eriod.
ethods
 clinical trial involving 90 climacteric women aged between
5 and 65 years, regardless of race, ethnicity and religion,
as conducted. The women were referred from outpatient
linics for menopause care (Centro de Saúde Reprodu-
iva Leide Morais and Maternidade Escola Januário Cicco;
atal, RN) and rheumatology (Hospital Universitário Onofre
opes, Universidade Federal do Rio Grande do Norte and
línica Integrada da Saúde, Universidade Potiguar; Natal,
N) after an initial screening. The study was reviewed and
pproved by the Research Ethics Committee of the Univer-
idade Potiguar under the protocol number 250/2010, CAAE
252.0.052.000-10. All participants signed an Informed Con-
ent Form, according to the norms of the Conselho Nacional
e Saúde, Resolution 196/1996. The research was conducted
n accordance with the Declaration of Helsinki, as revised in
008.
Considering that the study design involves estimates of
requencies and mean scores, sampling techniques with sta-
istical procedures were used, adopting an alpha of 5% and
 statistical power of 80%. Taking into consideration also the
esign effect and the occurrence of refusals and losses, it was
ecided to increase the sample size to build in a margin of
afety for possible sample losses.
The volunteers were divided into two groups: ﬁbromyalgia
FM) (n = 47) and control (n = 43) groups. The following inclu-
ion criteria were considered for FM group: (a) a diagnosis of
M established by a rheumatologist, according to the Ameri-
an College of Rheumatology (ACR) 1990 criteria2; (b) cognitive
bility to understand the purpose of the survey and to answer
he questionnaires; (c) not to be performing, at least dur-
ng one month, any type of physical therapy. For the control
roup, all inclusion criteria above mentioned were obeyed,
ith the exclusion of diagnosis of FM.  Exclusion criteria for
oth groups included: (a) presence of physical limitations; (b)
revious history of oophorectomy; (c) presence of diffuse con-
ective tissue diseases, chronic pelvic pain and irritable bowel
yndrome.
The volunteers were subjected to pre- and post-
ntervention assessments through questionnaires applied by
valuators trained in applying the research tools, individually
nd in a reserved place. All assessments were blinded, being
arried out by evaluators different of those who underwent
he physical therapy intervention. As for data collection,
he authors used a semistructured questionnaire to assess
he demographic characteristics (age, years of education,
ccupation, household income and marital status), besides
alidated instruments to measure quality of life speciﬁcally
uring menopause, climacteric signs and symptoms’ severity
nd sexual function.
The quality of life was assessed by the Utian Quality of
ife (UQoL) questionnaire, translated and validated in Brazil by
alvão et al. (2007),12 which proved to be a useful instrument to 5;5 5(3):209–215 211
quantify quality-of-life and well-being subjective assessments
in pre- and post-menopausal women. The instrument con-
tains 23 questions that comprise four distinct quality-of-life
domains, namely: occupational, health, sexual and emotional
domain. Each question of UQoL is answered by means of a 5
point scale, wherein the maximum and minimum values vary
in each domain. The higher the awarded score, the better the
quality of life.
The severity of climacteric symptoms was measured by
Blatt–Kupperman Menopausal Index (BKMI),13 an instrument
widely used both in clinical practice and in research settings
to monitor the effects of those various treatments used in
the climacteric phase, demonstrating high test–retest reliabil-
ity power. BKMI consists of 11 items, for which the patient
attributes scores according to the intensity of each symptom
(0 – none, 1 – mild, 2 – moderate, 3 – severe). The ﬁnal score is
determined by the sum of the respective scores of the above
symptoms, after their multiplication by conversion factors, in
order to measure quantitatively the intensity of climacteric
symptoms.
The participants’ sexual function was assessed by the Sex-
ual Quotient female version questionnaire (SQ-F), developed
and validated for the Portuguese idiom by Abdo (2006).14
This tool contains questions about various domains of sex-
ual activity for women (sexual desire, arousal, orgasm, and
their psychophysical correlates) scored from 0 to 100, where
the closer to 100, the better the sexual function.
After the pre-intervention assessment, all participants
initiated the proposed treatment, which was performed in
10 consecutive weeks, involving 20 sessions of pelvic ﬂoor
kinesiotherapy held twice a week, with 1-h/day duration,
conducted by one of the researchers. The proposed conduct
obeyed the sequence of perception, abdominoperineal dissoci-
ation, voluntary contraction and automation of the pelvic ﬂoor
associated with facilitating postures, pelvis mobilization and
breathing training at the time of pelvic ﬂoor contractions. Each
exercise was performed with a series of ten repetitions; each
contraction was sustained for 5 s, with 10 s of rest between
contractions, progressing to a 10-s support with 20 s of rest
after 10 sessions.
After ﬁnishing the intervention period, the patients were
reassessed, using the same survey instruments applied in the
pre-intervention period.
The obtained data were analyzed descriptively as the mean
and standard deviation for continuous and interval variables
and as percentages for dichotomous or ordinal categorical
variables. To meet the study objectives, an analysis of normal-
ity was performed using the Shapiro–Wilk test. To check the
inﬂuence of the intervention protocol in FM and menopause
groups, paired Student’s t-test was used; thus, the differ-
ence before and after intervention was estimated. In order
to estimate the size effect and the clinical impact of the
intervention, Cohen’s Kappa (d) was used. Values above 0.8
were considered as representing a strong effect size; between
0.5 and 0.8, a moderate effect; and below 0.5, a weak effect.
For detection of the inﬂuence of “group” variable, a mixed-
design analysis of variance (ANOVA) between the participants
was performed. These factors and their interactions were
entered into the prediction model for the following depend-
ent variables: BKMI, SQ-F and UQoL. All data were analyzed
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with the statistical software Statistical Package for Social
Science (SPSS) version 20.0, and a signiﬁcance level of 5% was
adopted.
Results
Of the 90 women selected for the study, seven dropped out
during the intervention or did not perform 80% of the sessions
(three in the control group and four in FM group). The alleged
reasons for withdrawal were related to personal reasons and to
incompatibility of time; thus, no adverse event was indicated
as the cause of the interruption.
A total of 83 participants completed the study, of which
43 were part of FM group and 40 were in the control group.
With regard to demographics, there was no statistically sig-
niﬁcant difference between groups at baseline. Regarding the
variables marital status, occupation and income, no difference
was observed between groups (p > 0.05) and in this sample,
in general, 62 (74.7%) participants had a steady partner, 43
(51.8%) exerted some off-home work and 43 (51.8%) had a fam-
ily income between 2 and 4 minimum wages. In Table 1 it can
be seen that the groups were homogeneous in all continuous
variables investigated previously to the treatment proposed
in the study. After the study period, no adverse events were
reported, and most patients showed satisfaction with the pro-
posed exercises.
Regarding the domains of quality of life analyzed by UQoL,
it was observed that the kinesiotherapy protocol allowed a
statistically signiﬁcant improvement for both FM and control
groups in all domains, when comparing pre- and post-
intervention intragroup results. Regarding the effect or clinical
impact of the intervention on the domains of quality of life,
it can be observed that, for the climacteric group, all domains
of UQoL showed a strong effect: physical (d = 0.72), emotional
(d = 1.02), health (d = 1.49) and sexual (d = 1.69), and this also
occurred with the FM group: occupational (d = 0.62), emotional
(d = 0.62), health (d = 0.97) and sexual (d = 1.00). In the post-
intervention intergroup evaluation, a statistically signiﬁcant
difference was observed in three of the four UQoL domains:
occupational (p = 0.01), health (p = 0.03) and sexual (p ≤ 0.00),
and kinesiotherapy provided better results in women in the
control group (Table 2).
In the evaluation of sexual function, it can be observed in
Table 3 that, after the intervention, both FM (37.48 vs. 43.34,
p < 0.001, d = 0.36) and control (38.80 vs. 50.67, p < 0.001, d = 0.67)
groups had their scores increased, with statistically signiﬁ-
cant differences. A weak clinical impact of the intervention
for FM group and a strong impact for the control group were
identiﬁed. In intergroup comparison, a statistically signiﬁ-
cant difference (p = 0.01) was detected, evidencing a more  clear
improvement in the control group.
By analyzing the intensity of menopause-related symp-
toms by BKMI, it is observed in Table 3 that the protocol
for pelvic ﬂoor kinesiotherapy resulted in a signiﬁcant
score reduction for both FM (34.06 vs. 23.23; pre- vs. post-
intervention, respectively, p < 0.001, d = 1.09) and control (30.15
vs. 19.20, p < 0.001, d = 1.08) groups, with a strong clini-
cal impact of the intervention for both groups. As for the 0 1 5;5 5(3):209–215
intergroup analysis, there was no statistically signiﬁcant dif-
ference between groups (p = 0.73).
Discussion
Our ﬁndings demonstrate that pelvic ﬂoor kinesiotherapy in
climacteric women can improve their quality of life, sexual
function and climacteric symptoms. Despite the very frequent
complaints of sexual dysfunction, menopause related signs
and symptoms and a negative impact on the quality of life
in women with ﬁbromyalgia,15–20 and despite previous stud-
ies showing positive effects of pelvic ﬂoor kinesiotherapy for
these complaints,21,22 to date there were no reports in the liter-
ature on the use of this intervention as part of the treatment of
such disorders considering this particular group of climacteric
women. Thus, this is the ﬁrst report in the literature pointing
out that the clinical impact of pelvic ﬂoor kinesiotherapy is
different in women with an associated diagnosis of ﬁbromyal-
gia, which may have important implications for the clinical
management of these patients.
Regarding the domains of quality of life, a signiﬁcant
improvement in both groups was demonstrated after the
pelvic ﬂoor kinesiotherapy sessions, which corroborates
the results of previous studies demonstrating that such
physical therapy intervention provides signiﬁcant improve-
ment in quality of life of women with dysfunctional pelvic
ﬂoor.21–23 A recent study in Nigerian women in the climacteric
phase, which aimed to investigate the effect of a twelve-
week program of physical exercises and pelvic ﬂoor muscle
strengthening, showed that the intervention led to a signiﬁ-
cant improvement on quality of life in general.24
Although ﬁbromyalgia is directly linked to emotional and
psychological disorders,25 the climacteric period, by itself, is
a difﬁcult transition phase, which involves a complex process
of emotional and bodily changes, being under the inﬂuence of
multiple factors such as personal and family life history, envi-
ronment, culture, customs and personal peculiarities. Such
aspects resonate differently in each woman, with direct inter-
ference in their feelings and quality of life,26 a fact that
resembles and often deﬁnes the symptoms of menopause as
being part of ﬁbromyalgia.10
In the analyzed sample, FM group showed limitations in
the kinesiotherapeutic results in relation to “occupational”
and “health” domains of quality of life. Such limitations were
evidenced in another study27 which proposed to analyze the
difﬁculty of a continuous work for women with ﬁbromyal-
gia; the authors observed that limitations in physical capacity
and the increased need for rest, due to the chronicity of the
pain process, were the main reasons associated with the dif-
ﬁculty to manage physical, psychosocial and organizational
work demands. It is also known that ﬁbromyalgia is charac-
terized by being a persistent and debilitating disorder, causing
a negative effect on people’s lives and affecting their ability
to work and engage in daily activities.28,29 These effects arise
mainly from the picture of a chronic and widespread muscu-
loskeletal pain, which is presented as a determining factor in
the worsening of health problems and in limitations in daily
life.30–32
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Table 1 – Demographic and clinical characteristics of ﬁbromyalgia and control groups at baseline.
Variables Control
Mean (±SD)
Fibromyalgia
Mean (±SD)
p
Age, years 53.27 (5.99) 52.83 (6.27) 0.76
Years of study 10.55 (4.47) 10.74 (4.66) 0.84
Quality of life, UQoL
Occupation 23.90 (6.70) 22.04 (6.29) 0.19
Health 15.87 (5.35) 15.44 (4.71) 0.69
Emotional 16.45 (4.82) 16.18 (4.42) 0.79
Sexual 7.77 (2.49) 7.62 (2.58) 0.79
Total 64.25 (13.65) 61.30 (10.83) 0.27
Climacteric symptoms, BKMI 30.15 (10.93) 34.06 (10.45) 0.09
Sexual function, SQ-F 38.80 (18.97) 37.48 (16.65) 0.73
p ≤ 0.05, non-paired Student’s t-test.
Table 2 – Analysis of intragroup and intergroup quality of life, considering pre- and post-intervention periods.
Variables Control Fibromyalgia Intergroup
difference, P
Pre Post Intragroup
difference, p
Pre Post Intragroup
difference, p
Mean (±SD) Mean (±SD) Mean (±SD) Mean (±SD)
UQoL emotional 16.45 (±4.82) 21.02 (±4.12) <0.00a,b 16.18 (±4.42) 18.79 (±3.98) <0.00a,b 0.09
UQoL occupational 23.90 (±6.70) 28.37 (±5.56) <0.00a,b 22.04 (±6.29) 25.97 (±6.68) <0.00a,b 0.01c
UQoL health 15.87 (±5.35) 23.55 (±4.94) <0.00a,b 15.44 (±4.71) 20.58 (±5.81) <0.00a,b 0.03c
UQoL sexual 7.77 (±2.49) 11.72 (±2.18) <0.00a,b 7.62 (±2.58) 10.00 (±2.14) <0.00a,b 0.00c
Pre-treatment and post-treatment values expressed as mean and standard deviation.
a p < 0.001 (paired Student’s t-test for intragroup analysis).
b Strong to moderate clinical impact of the intervention (Cohen’s Kappa test).
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fc p < 0.05 (mixed-design analysis of variance (ANOVA) between partic
Sexual function is currently regarded as a key element
or the general well-being and quality of life in middle-aged
omen, and this factor is inﬂuenced by socio-demographic,
iological and behavioral variables relevant to the stage of life
here these women are.33,34 In previous studies on the inves-
igation of sexual dysfunctions, it was possible to observe that
35,36his complaint is quite common in climacteric women;
nd when investigated in women with rheumatic diseases, it
as observed that women with ﬁbromyalgia exhibit a higher
requency, compared to other diseases.20
Table 3 – Analysis of intra- and intergroup of sexual function th
symptoms, considering pre- and post-intervention.
Variables Control 
Pre Post Intragroup
difference, p
Mean (±SD) Mean (±SD) 
Sexual function,
SQ-F
38.80 (±18.97) 50.67 (±16.46) <0.00a,b
Climacteric
symptoms, BKMI
30.15 (±10.93) 19.20 (±9.34) <0.00a,b
Pre-treatment and post-treatment values expressed as mean and standard
a p < 0.001 (paired Student’s t-test for intragroup analysis).
b Strong to moderate clinical impact of the intervention (Cohen’s Kappa t
c p < 0.05 (mixed-design analysis of variance (ANOVA) between participants in intergroup analysis).
Pelvic ﬂoor muscle training provides stability, resistance
and strength of these muscles, increased vaginal tone and
consequently an improvement in sexual function, by allow-
ing a better awareness and possibly a positive impact, both on
orgasm and in sexual arousal.37–39 In our study, the effects
observed in the FM group were less important than those
observed in climacteric women without ﬁbromyalgia. This
ﬁnding can be attributed to the fact that psychiatric symp-
toms, such as depression, are quite common in women with
ﬁbromyalgia, which could exert a direct and detrimental
rough SQ-F questionnaire and severity of climacteric
Fibromyalgia Intergroup
difference, P
Pre Post Intragroup
difference, p
Mean (±SD) Mean (±SD)
37.48 (±16.65) 43.34 (±15.55) <0.00a 0.01c
34.06 (±10.45) 23.23 (±9.29) <0.00a,b 0.73
 deviation.
est).
ts in intergroup analysis).
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inﬂuence on the sexual function of these women, thus
complicating the attainment of more  signiﬁcant therapeutic
responses.40
The climacteric symptoms, due to hormonal changes as
hypoestrogenism, negatively inﬂuence the quality of life and
functionality of women who  are experiencing this phase.41
The treatment with kinesiotherapy exercises for pelvic ﬂoor,
although not related in previous studies as a therapeutic
way to ease the intensity of climacteric symptoms, allowed
a homogeneous reduction in the scores of BKMI for both
groups, showing that the diagnosis of ﬁbromyalgia does not
interfere directly in the impact of an exercise program for cli-
macteric symptoms. Based on these results, it is plausible to
suggest that even patients with ﬁbromyalgia would beneﬁt
with pelvic ﬂoor kinesiotherapy, for improvement of their cli-
macteric symptoms. Despite this, a recent study emphasizes
that women with ﬁbromyalgia exhibit hypersensitivity to pain
and worsening of signs and symptoms related to menopause,
when compared to healthy women, in consequence of the
early onset of menopause and, thus, a reduced exposure time
of these women to estrogen.42
Given the ﬁndings highlighted in this study, we  may
suggest that pelvic ﬂoor kinesiotherapy provides signiﬁcant
improvement in quality of life in occupation, emotional,
health and sexual domains, as well as in climacteric symp-
toms and also in sexual function. However, when the
improvement in the group diagnosed with ﬁbromyalgia was
compared with that in the control group, it was observed that
ﬁbromyalgia exerts a limiting effect on the improvement in
health, occupational and sexual domains of quality of life and
also in sexual functioning in climacteric women.
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